Wolf Haldenstein Files Securities Class Action Lawsuit Against Zynex, Inc.
NEW YORK, March 26, 2025 – Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of shareholders who purchased Zynex, Inc. (NASDAQ: ZYXI) common stock between March 13, 2023, and March 11, 2025, inclusive (the “Class Period”).
Allegations Against Zynex, Inc.
The complaint alleges that Zynex, Inc. and certain of its officers and directors made false and misleading statements and failed to disclose material information during the Class Period, violating Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. Specifically, the complaint alleges that the defendants made false and misleading statements regarding the Company’s financial condition and business prospects.
Background of Zynex, Inc.
Zynex, Inc. is a Colorado-based medical technology company that designs, manufactures, and markets non-invasive medical devices and therapeutic systems. The Company’s products include electrotherapy devices, transcutaneous electrical nerve stimulation (TENS) devices, and functional electrical stimulation (FES) systems, among others.
The Class Period and Events Leading to the Lawsuit
The complaint alleges that during the Class Period, Zynex, Inc. made false and misleading statements regarding its financial condition and business prospects. For example, the defendants claimed that the Company’s revenue growth was strong and that it was making progress in expanding its product offerings. However, the truth was that the Company was experiencing declining revenue and was facing significant challenges in its business.
The Disclosure of Truth and its Impact on Zynex, Inc.
On March 11, 2025, Zynex, Inc. issued a press release announcing its financial results for the fourth quarter and full year 2024. The press release revealed that the Company’s revenue for the fourth quarter had decreased by 17% compared to the same period in the previous year, and that the Company was experiencing significant challenges in its business. This news sent the price of Zynex, Inc. stock plummeting, causing significant harm to investors who had purchased stock during the Class Period.
The Effects on Individual Investors
For individual investors who purchased Zynex, Inc. stock during the Class Period, the lawsuit offers the opportunity to recover their losses. The securities class action process allows investors to hold companies and their executives accountable for providing false and misleading information, and to seek compensation for their losses.
The Effects on the World
The securities class action lawsuit against Zynex, Inc. is an important reminder of the need for transparency and honesty in the business world. When companies and their executives provide false and misleading information to investors, it undermines the integrity of the financial markets and can cause significant harm to individual investors and the economy as a whole.
Conclusion
The securities class action lawsuit against Zynex, Inc. is an important step in holding the Company and its executives accountable for providing false and misleading information to investors during the Class Period. It offers individual investors the opportunity to seek compensation for their losses, and sends a strong message that transparency and honesty are essential in the business world.
- Wolf Haldenstein Adler Freeman & Herz LLP has filed a securities class action lawsuit against Zynex, Inc.
- The lawsuit alleges that the Company and certain officers and directors made false and misleading statements during the Class Period.
- Zynex, Inc. is a Colorado-based medical technology company that designs, manufactures, and markets non-invasive medical devices and therapeutic systems.
- The Class Period was between March 13, 2023, and March 11, 2025.
- The complaint alleges that the defendants made false and misleading statements regarding the Company’s financial condition and business prospects.
- On March 11, 2025, Zynex, Inc. announced financial results revealing declining revenue and significant challenges in its business.
- The lawsuit offers individual investors the opportunity to seek compensation for their losses.
- The securities class action lawsuit sends a strong message about the importance of transparency and honesty in the business world.
